ORTHOCARE pushes recovery slippers with EU test file and EVA customization

Xiamen Jiecheng Import & Export, the exporter behind ORTHOCARE, says its EVA footwear now has an Intertek test report valid for the EU market through January 2031. The company is pairing that compliance file with customizable hardness, OEM/ODM tooling and 1 million-pair annual capacity to target recovery-footwear buyers overseas.

Why it matters: - ORTHOCARE is trying to turn recovery footwear into a repeatable B2B supply business, where compliance files, customization and production capacity matter as much as branding. - The company’s EU-valid test report gives importers one document they can reuse across multiple buying cycles. - That can lower friction for brands, e-commerce sellers and medical-adjacent buyers entering the recovery-footwear category.

What happened: - Xiamen Jiecheng Import & Export Co., Ltd., the exporter behind ORTHOCARE, holds an Intertek footwear test report for its EVA flip-flop range in the European Union market. - The report, numbered FJXT80162636, was issued on 14 January 2026 by Intertek Testing Services Shenzhen Ltd. Xiamen Branch. - The document expires on 13 January 2031. - The company was founded in 2017 and is headquartered in Xiamen, Fujian Province. - ORTHOCARE exports foot-health and comfort footwear exclusively to overseas buyers. - The company lists South Asia, the European Union, the United States and Australia as its stated markets. - Its distribution reaches more than 50 countries and regions.

The details: - The Intertek file covers slip resistance, toe-post strength, outsole abrasion resistance, colour fastness to light, PAH content, cadmium content, total lead content and phthalates content. - The referenced standards include SATRA TM144:2021, SATRA TM118:2025, ISO 20871:2018, ISO 105 B02-2014, AfPS GS 2019:01 PAK, EN 17132:2019 or ISO 16190:2021, EN 1122:2001 Method B, IEC 62321:2008 or ISO 11885:2007, EPA 3051A:2007 and CPSC-CH-C1001-09.4. - Covered models include the EVA flip flop A05 and EVA thong A08 in sizes 36–46, the EVA recovery slipper A07 in sizes 40–46, and the EVA slipper D01 in sizes 36–44. - All four models use EVA as the primary material with a softness specification of 38–50 degrees. - ORTHOCARE says its EVA range uses an in-house microcellular closed-cell EVA formulation. - The formulation is designed to improve rebound, resistance to compression set and cushioning retention across wear cycles. - Hardness is specified in Shore A and can be customized between 38 and 50 degrees. - Softer 35–40 degree configurations are available on request. - The recovery line uses an anatomically contoured footbed, a deep heel cup and medial arch support. - Model L25 is a two-tone EVA recovery slipper with arch support across sizes 36–46 and 38–50 degrees of softness. - The wider EVA program includes slides, thongs, clogs, nurse shoes and garden shoes. - Model-level size ranges run from 35–40 on the JFC651 slide to 39–46 on the C22 nurse shoe and the A02 recovery clog shoe. - The clog and garden models also use the 38–50 degree softness range and EVA primary material. - ORTHOCARE’s second platform is cork-footbed construction for recovery slippers and arch-support styles. - Cork models use 3mm genuine leather uppers, a latex cork midsole with an SBR layer and suede backing, and a wear-resistant EVA outsole. - Linings are suede as standard, with a wool winter edition available. - Sizes run from 36–46 across the cork range. - Outsole bottom patterns are available in standard or custom designs. - The cork line includes closed-toe models CS01, CS05, CS06 and CS07, the adjustable criss-cross strap clog CS02, platform cork sandals CS03, the latex cork thong CS09 and the CS10 arch support latex cork sandal. - The company’s OEM/ODM work includes original last development, sole geometry modification and strap tooling. - New model development from a reference sample or technical brief typically takes 25–35 days. - Private-label services cover colour customization, logo application and embossing, material selection, branded insole printing, construction and design modification, and retail packaging design. - Sampling can start from a single pair. - Bulk production has a minimum order quantity of 500 pairs per colour. - Production lead time is 30–45 days. - The company also supports customized Shore A hardness, arch support customization, full-model customization, and testing and validation requests. - Manufacturing runs across the Xiamen headquarters and a production base in Jinjiang, Fujian Province. - The company reports more than 15 production lines, a plant area of over 10,000 square metres, annual capacity of 1,000,000 pairs and monthly capacity of 100,000 pairs. - A five-person research and development team works on material formulation and product development. - Quality control includes 100% inspection before shipment and a three-month quality promise after shipment. - Third-party pre-shipment inspection is supported. - SGS or BV test reports can be provided for EU and United States market entry requirements. - The company cites a five-year relationship with a South Korean brand owner covering EVA arch support recovery footwear. - It reports annual order volume of 1,000,000 pairs and 100% stable production and 100% on-time shipment over that period. - The company says its products have also been used in clinical rehabilitation environments. - Target markets listed by the company include the United States, Canada, Australia, South Korea, Japan and EU countries. - Those markets are served through sports recovery, occupational health, medical podiatry referral and lifestyle wellness channels.

Between the lines: - The certification file matters because footwear buyers often screen suppliers first for documentation, then for price. - The 500-pair MOQ and single-pair sampling make the offering more accessible to smaller brands than container-scale sourcing. - The combination of EVA and cork platforms broadens ORTHOCARE’s appeal to buyers who want both soft foam recovery styles and firmer footbed constructions. - The company is competing in a market where brands such as OOFOS and Kane Footwear rely on consumer marketing, while export manufacturers compete on tooling speed, material specs and compliance. - Market research cited in the release points to growth driven by aging consumers, sports participation and greater attention to foot health. - The same research suggests medical and post-surgical recovery remains the most documentation-heavy segment.

What's next: - ORTHOCARE will likely use the EU test file, hardness customization and OEM/ODM tooling to win more private-label and overseas recovery-footwear programs. - The company’s capacity suggests it can scale beyond initial sampling and smaller test orders if buyers convert. - Future demand will depend on how fast importers turn compliance documentation into listings in Europe and North America. - Growth in post-surgical and sports recovery footwear will also shape how much volume the company can capture.

The bottom line: - ORTHOCARE is pitching itself as a documentation-ready recovery footwear supplier, not just a shoe maker. - Its core pitch is simple: customizable EVA, a long-dated EU test report and the capacity to supply private-label buyers at scale.